(Q42168171)

17 October 2017

title

Suppression of angiogenesis and tumor growth by adenoviral-mediated gene transfer of pigment epithelium-derived factor (English)

1 reference

17 October 2017

1 reference

5

1 reference

17 October 2017

Lin Wang

1

1 reference

17 October 2017

Volker Schmitz

2

1 reference

17 October 2017

Alberto Perez-Mediavilla

3

1 reference

17 October 2017

Iñigo Izal

4

1 reference

17 October 2017

Cheng Qian

6

1 reference

17 October 2017

publication date

1 July 2003

1 reference

17 October 2017

1 reference

17 October 2017

volume

8

1 reference

17 October 2017

issue

1

1 reference

17 October 2017

page(s)

72-79

1 reference

PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity

17 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Pigment epithelium-derived factor behaves like a noninhibitory serpin. Neurotrophic activity does not require the serpin reactive loop

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Pigment epithelium-derived factor (PEDF) protects motor neurons from chronic glutamate-mediated neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

NFkappaB activation is required for the neuroprotective effects of pigment epithelium-derived factor (PEDF) on cerebellar granule neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Pigment epithelium-derived factor delays the death of photoreceptors in mouse models of inherited retinal degenerations

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Pigment epithelium-derived factor: a potent inhibitor of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Pigment-epithelium-derived factor--a key coordinator of retinal neuronal and vascular functions

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

PEDF: Raising both hopes and questions in controlling angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Angiogenesis in cancer and other diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

What Is the Evidence That Tumors Are Angiogenesis Dependent?

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Molecular mechanisms of blood vessel growth

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Vascular-specific growth factors and blood vessel formation

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Down-regulation of vascular endothelial growth factor and up-regulation of pigment epithelium-derived factor: a possible mechanism for the anti-angiogenic activity of plasminogen kringle 5

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Putting the neo into neoangiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Origin of endothelial progenitors in human postnatal bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Origins of circulating endothelial cells and endothelial outgrowth from blood

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Circulating endothelial precursors: mystery, reality, and promise

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Gene therapy for antiangiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Gene therapy strategies for tumor antiangiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Antiangiogenic gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

High-capacity adenoviral vectors for gene transfer and somatic gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Suppression of angiogenesis by lentiviral delivery of PEX, a noncatalytic fragment of matrix metalloproteinase 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Treatment with sulfasalazine or sulfapyridine, but not 5-aminosalicyclic acid, inhibits basic fibroblast growth factor-induced endothelial cell chemotaxis

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900128-X

7 January 2021

10.1016/S1525-0016(03)00128-X

Identifiers

DOI

1 reference

17 October 2017

1 reference